TD Waterhouse Canada Inc. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 82 filers reported holding SEELOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
TD Waterhouse Canada Inc. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$486
-79.6%
2,400
+20.0%
0.00%
Q2 2023$2,380
+61.7%
2,0000.0%0.00%
Q1 2023$1,472
+4.2%
2,0000.0%0.00%
Q4 2022$1,412
-32.1%
2,0000.0%0.00%
Q3 2022$2,0802,0000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
PIPER SANDLER & CO. 164,778$361,0000.48%
Uniplan Investment Counsel, Inc. 692,623$1,516,0000.10%
ARDSLEY ADVISORY PARTNERS LP 50,000$110,0000.02%
A.R.T. Advisors, LLC 52,342$115,0000.01%
WEDBUSH SECURITIES INC 16,000$35,0000.00%
WealthPLAN Partners, LLC 10,000$17,0000.00%
Renaissance Technologies 929,465$2,036,0000.00%
Squarepoint Ops LLC 28,629$63,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 17$00.00%
View complete list of SEELOS THERAPEUTICS INC shareholders